Tumor- und Brustzentrum ZeTuP Silberturm

Recent papers from Tumor- und Brustzentrum ZeTuP Silberturm

1. An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42The Breast · 2025
2. 270MO An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: Results of the validation study phase IV EORTC QLQ-BR42ESMO Open · 2024
3. Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical ProstatectomyPathobiology · 2023
4. Marine Compounds and Cancer: Updates 2022Marine Drugs · 2022
5. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerScientific Reports · 2020
6. Anti-Angiogenics: Current Situation and Future PerspectivesOncology Research and Treatment · 2018
7. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemiaHaematologica · 2017
8. Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cellsLeukemia & lymphoma/Leukemia and lymphoma · 2017
9. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancerEuropean Journal of Cancer · 2016
10. Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionMolecular Oncology · 2015
11. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumoursOncotarget · 2015
12. A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumUrologia Internationalis · 2015
13. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology · 2015
14. Estimates of benefits and harms of prophylactic use of aspirin in the general populationAnnals of Oncology · 2014
15. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancerOncotarget · 2014
16. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology · 2013
17. The transcriptional co-repressor Grg3/Tle3 promotes pancreatic endocrine progenitor delamination and β-cell differentiationDevelopment · 2012
18. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology · 2011
19. The antihormonal preventive therapy of breast cancer and prostate cancerHormone Molecular Biology and Clinical Investigation · 2011
20. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancerBritish Journal of Cancer · 2009